Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lopez, O.L.
Right arrow Articles by DeKosky, S.T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lopez, O.L.
Right arrow Articles by DeKosky, S.T.
Neurology 2000;55:1863-1869
© 2000 American Academy of Neurology


Articles

Research evaluation and diagnosis of possible Alzheimer’s disease over the last two decades: II

O.L. Lopez, MD;, J.T. Becker, PhD;, W. Klunk, MD;, J. Saxton, PhD;, R.L. Hamilton, MD;, D.I. Kaufer, MD;, R.A. Sweet, MD;, C. Cidis Meltzer, MD;, S. Wisniewski, PhD;, M.I. Kamboh, MD; and S.T. DeKosky, MD

From the Alzheimer’s Disease Research Center (Drs. Lopez, Becker, Klunk, Saxton, Hamilton, Kaufer, Sweet, Wisniewski, Kamboh, and DeKosky) and the Departments of Psychiatry (Drs. Lopez, Becker, Klunk, Saxton, Kaufer, Sweet, and DeKosky), Neurology (Drs. Lopez, Becker, Kaufer, and DeKosky), Pathology (Neuropathology) (Dr. Hamilton), Radiology (Dr. Meltzer), Epidemiology (Dr. Wisniewski), and Genetics (Dr. Kamboh), University of Pittsburgh School of Medicine, PA.

Address correspondence and reprint requests to Dr. Oscar L. Lopez, Neuropsychology Research Program, Oxford Building, 3501 Forbes Avenue, Suite 830, Pittsburgh, PA 15213.

OBJECTIVE: To describe the experience of a research clinic diagnosing possible AD during the last two decades.

BACKGROUND: The National Institute of Neurological and Communicative Disorders and Stroke–Alzheimer’s Disease and Related Disorders Association criteria for possible AD are generally used to indicate that a patient has AD in association with another disease process that could by itself cause dementia. There are no studies describing how these criteria should be applied, and there are no descriptions of functional and cognitive progression or survival in possible AD.

METHODS: The authors examined the clinical characteristics of 267 patients diagnosed with possible AD at the AD Research Center of Pittsburgh from 1983 to 2000 and the likelihood of arriving at four endpoints: Mini-Mental State Examination score of <= 9, Blessed Dementia Rating Scale for activities of daily living score of >= 12, nursing home admission, and death.

RESULTS: The possible AD classification has been simplified in six categories: possible AD with cerebrovascular disease (CVD) (69%), with history of alcohol abuse (15%), with history of depression (7%), with thyroid disease (4%), with history of head trauma (6%), with vitamin B12 deficiency (6%), and with other disease process that may have affected the clinical presentation of AD (4%). The presence of CVD, history of alcohol abuse, and history of depression concomitant with the onset of dementia were associated with time to death. Neither thyroid disease, history of head trauma, nor vitamin B12 deficiency were associated with any of the four endpoints.

CONCLUSION: This cohort showed that comorbid conditions that can affect cognition delineate clearly defined subgroups in AD. The presence of environmental or other brain disorders sufficient to produce dementia appears to affect physical survival in patients with AD, but not functional and cognitive decline or institutionalization.




This article has been cited by other articles:


Home page
BrainHome page
M. D. Ikonomovic, W. E. Klunk, E. E. Abrahamson, C. A. Mathis, J. C. Price, N. D. Tsopelas, B. J. Lopresti, S. Ziolko, W. Bi, W. R. Paljug, et al.
Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease
Brain, June 1, 2008; 131(6): 1630 - 1645.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
O. L. Lopez, L. H. Kuller, P. D. Mehta, J. T. Becker, H. M. Gach, R. A. Sweet, Y. F. Chang, R. Tracy, and S. T. DeKosky
Plasma amyloid levels and the risk of AD in normal subjects in the Cardiovascular Health Study
Neurology, May 6, 2008; 70(19): 1664 - 1671.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
O. L. Lopez, J. T. Becker, R. A. Sweet, F. J. Martin-Sanchez, and R. L. Hamilton
Lewy bodies in the amygdala increase risk for major depression in subjects with Alzheimer disease.
Neurology, August 22, 2006; 67(4): 660 - 665.
[Abstract] [Full Text] [PDF]


Home page
AJGPHome page
P. A. Wilkosz, S. Miyahara, O. L. Lopez, S. T. DeKosky, and R. A. Sweet
Prediction of Psychosis Onset in Alzheimer Disease: The Role of Cognitive Impairment, Depressive Symptoms, and Further Evidence for Psychosis Subtypes
Am J Geriatr Psychiatry, April 1, 2006; 14(4): 352 - 360.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
J. T. Becker, S. W. Davis, K. M. Hayashi, C. C. Meltzer, A. W. Toga, O. L. Lopez, P. M. Thompson, and for the Imaging Methods and Analysis in Geriatrics
Three-dimensional Patterns of Hippocampal Atrophy in Mild Cognitive Impairment
Arch Neurol, January 1, 2006; 63(1): 97 - 101.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
G B Frisoni, P h Scheltens, S Galluzzi, F M Nobili, N C Fox, P H Robert, H Soininen, L-O Wahlund, G Waldemar, and E Salmon
Neuroimaging tools to rate regional atrophy, subcortical cerebrovascular disease, and regional cerebral blood flow and metabolism: consensus paper of the EADC
J. Neurol. Neurosurg. Psychiatry, October 1, 2003; 74(10): 1371 - 1381.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
D. T. Villareal, E. Grant, J. P. Miller, M. Storandt, D. W. McKeel, and J. C. Morris
Clinical outcomes of possible versus probable Alzheimer's disease
Neurology, September 9, 2003; 61(5): 661 - 667.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
O L Lopez, J T Becker, S Wisniewski, J Saxton, D I Kaufer, and S T DeKosky
Cholinesterase inhibitor treatment alters the natural history of Alzheimer's disease
J. Neurol. Neurosurg. Psychiatry, March 1, 2002; 72(3): 310 - 314.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
O. L. Lopez, J. T. Becker, D. I. Kaufer, R. L. Hamilton, R. A. Sweet, W. Klunk, and S. T. DeKosky
Research Evaluation and Prospective Diagnosis of Dementia With Lewy Bodies
Arch Neurol, January 1, 2002; 59(1): 43 - 46.
[Abstract] [Full Text] [PDF]


Home page
AM J ALZHEIMERS DIS OTHER DEMENHome page
T. Fritsch, M. J. McClendon, K. A. Smyth, A. J. Lerner, C. H. Chen, G. J. Petot, S. M. Debanne, A. Soas, and R. P. Friedland
Effects of educational attainment on the clinical expression of Alzheimer's disease: Results from a research registry
American Journal of Alzheimer's Disease and Other Dementias, November 1, 2001; 16(6): 369 - 376.
[Abstract] [PDF]


Home page
Arch NeurolHome page
D. L. Sukonick, B. G. Pollock, R. A. Sweet, B. H. Mulsant, J. Rosen, W. E. Klunk, K. B. Kastango, S. T. DeKosky, and R. E. Ferrell
The 5-HTTPR*S/*L Polymorphism and Aggressive Behavior in Alzheimer Disease
Arch Neurol, September 1, 2001; 58(9): 1425 - 1428.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
O.L. Lopez, J.T. Becker, W. Klunk, J. Saxton, R.L. Hamilton, D.I. Kaufer, R.A. Sweet, C. Cidis Meltzer, S. Wisniewski, M.I. Kamboh, et al.
Research evaluation and diagnosis of probable Alzheimer's disease over the last two decades: I
Neurology, December 26, 2000; 55(12): 1854 - 1862.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by AAN Enterprises, Inc.